olmesartan has been researched along with Metabolic Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkins, C; Kieu, Z; Kitazawa, M; Maitra, N; Mejias-Ortega, M; Nishiyama, A; Ortiz, RM; Peng, M; Rodriguez, R; Rodriguez-Ortiz, CJ; Thorwald, MA; Valenzuela, J | 1 |
| Akbal, E; Akyürek, N; Akyürek, Ö; Güneş, F | 1 |
| Boutouyrie, P; Laurent, S | 1 |
| Ott, C; Raff, U; Schmieder, RE; Schneider, MP; Walker, S | 1 |
| Schlimpert, V | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Ishihara, Y; Kohno, M; Kosaka, H; Mizukawa, M; Noma, T; Obayashi, A; Ohmori, K; Yoshida, J; Yukiiri, K | 1 |
| Comi-Diaz, C; Martinez-Martin, FJ; Pedrianes-Martin, P; Peiro-Martinez, I; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
| Makris, T; Stefanadis, C; Thomopoulos, C; Tsioufis, C | 1 |
| McInnes, GT | 1 |
| Halimi, S | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A | 1 |
| Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N | 1 |
| Fujitani, Y; Hirose, T; Ikeda, F; Kawamori, R; Mita, T; Nakayama, S; Shimizu, T; Uchino, H; Watada, H | 1 |
1 review(s) available for olmesartan and Metabolic Syndrome
| Article | Year |
|---|---|
[Primary cardiorenal prevention in patients with type-2 diabetes. The Roadmap study].
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Imidazoles; Incidence; Kidney Failure, Chronic; Male; Meta-Analysis as Topic; Metabolic Syndrome; Multicenter Studies as Topic; Placebos; Primary Prevention; Randomized Controlled Trials as Topic; Rats; Rats, Inbred Strains; Risk Factors; Sex Factors; Tetrazoles; Time Factors; Treatment Outcome | 2005 |
4 trial(s) available for olmesartan and Metabolic Syndrome
| Article | Year |
|---|---|
Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carotid Arteries; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Metabolic Syndrome; Middle Aged; Pulse Wave Analysis; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2014 |
Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Hemodynamics; Humans; Imidazoles; Male; Metabolic Syndrome; Middle Aged; Pulse Wave Analysis; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2015 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
Topics: Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Incidence; Insulin Resistance; Intercellular Adhesion Molecule-1; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Single-Blind Method; Tetrazoles; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2011 |
9 other study(ies) available for olmesartan and Metabolic Syndrome
| Article | Year |
|---|---|
Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Metabolic Syndrome; Obesity; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptors, Angiotensin | 2023 |
Peroxisome proliferator-activated receptor gamma concentrations in newly diagnosed hypertension patients and the metabolic effects of olmesartan.
Topics: Adult; Antihypertensive Agents; Case-Control Studies; Cholesterol; Female; Humans; Hypertension; Imidazoles; Male; Metabolic Syndrome; Middle Aged; PPAR gamma; Tetrazoles; Triglycerides; Waist Circumference | 2014 |
[Optimizing antihypertensive therapy].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Randomized Controlled Trials as Topic; Tetrazoles | 2015 |
Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Topics: Adiponectin; Adipose Tissue, White; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Cardiovascular System; Drug Therapy, Combination; Eating; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lipids; Male; Metabolic Syndrome; Nitric Oxide Synthase Type III; Oxidation-Reduction; Pravastatin; Rats; Rats, Inbred OLETF; RNA, Messenger; Superoxides; Tetrahydrofolate Dehydrogenase; Tetrazoles | 2009 |
The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Body Mass Index; Comorbidity; Drug Therapy, Combination; Endpoint Determination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Life Style; Metabolic Syndrome; Tetrazoles; Treatment Outcome | 2011 |
The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metabolic Syndrome; Risk Factors; Tetrazoles; Treatment Outcome | 2011 |
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dietary Proteins; Disease Models, Animal; Endothelium, Vascular; Hydralazine; Hypertension, Renovascular; Imidazoles; Kidney; Male; Metabolic Syndrome; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Tetrazoles | 2007 |
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Inflammation; Japan; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles | 2008 |